secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2026-08-10T20:08:59+00:00
Accession:  0001773751-26-000161
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers Q2 revenue up 38% to $753M; raises FY26 guidance to $3.1-3.3B
-------------------------------------------------------------------------

- Q2 revenue $753.2M, +38% YoY; subscribers 2.89M, +19% YoY.
- Net loss $86.3M vs income $42.5M; gross margin 64% vs 76%; Adjusted EBITDA $60.3M.
- International revenue up 1,641% YoY to $131.4M, boosted by Eucalyptus acquisition.
- Raises FY26 revenue guidance to $3.1-3.3B and Adjusted EBITDA to $275-325M.
- Reaffirms 2030 targets of $6.5B revenue and $1.3B Adjusted EBITDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375126000161/0001773751-26-000161-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375126000161/hims-20260810.htm
  HTML page:      https://secwatch.observer/filing/0001773751-26-000161

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer